| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | chromatin organization | ZMYND11 EP400 ZMYND8 CHD2 MSL1 ZDBF2 TRIP12 SMYD2 DNAJC2 RLF RIF1 SETBP1 PWWP3A MYOCD MPHOSPH8 CHD6 DNMT1 HDAC2 | 3.34e-06 | 896 | 118 | 18 | GO:0006325 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | MED6 ZMYND11 EP400 ZMYND8 CHD2 MSL1 ZDBF2 TRIP12 SMYD2 DNAJC2 RLF RIF1 SETBP1 PWWP3A MYOCD MPHOSPH8 CHD6 DNMT1 HDAC2 | 3.83e-06 | 999 | 118 | 19 | GO:0071824 |
| GeneOntologyCellularComponent | nuclear body | RAD18 REXO4 HIVEP1 EP400 CIR1 SLU7 MSL1 CWC22 TRIP12 REXO1 RSRC1 NCBP3 ANKRD2 SETBP1 ZNF638 PRDM15 | 7.27e-05 | 903 | 122 | 16 | GO:0016604 |
| GeneOntologyCellularComponent | nuclear speck | 2.21e-04 | 431 | 122 | 10 | GO:0016607 | |
| HumanPheno | Sleep paralysis | 4.09e-05 | 10 | 37 | 3 | HP:0025233 | |
| HumanPheno | REM parasomnia | 4.09e-05 | 10 | 37 | 3 | HP:5200299 | |
| HumanPheno | Abnormal hypnagogia | 4.09e-05 | 10 | 37 | 3 | HP:5200296 | |
| HumanPheno | Hypnagogic hallucination | 4.09e-05 | 10 | 37 | 3 | HP:0002519 | |
| MousePheno | anophthalmia | 3.72e-05 | 246 | 93 | 9 | MP:0001293 | |
| MousePheno | cardiac edema | 6.00e-05 | 12 | 93 | 3 | MP:0012270 | |
| MousePheno | abnormal embryo development | ELOA EP400 TRAF3IP1 ENPP2 KIF16B DYNC2I1 NLRP2 TRIP12 REXO1 INTS10 BMP2 TOMM70 RIF1 GRK2 SARS1 ANKRD11 CC2D2A MYOCD CLSPN PRDM15 AFF4 DNMT1 | 7.13e-05 | 1370 | 93 | 22 | MP:0001672 |
| Domain | ERO1 | 4.03e-05 | 2 | 119 | 2 | PF04137 | |
| Domain | Ero1 | 4.03e-05 | 2 | 119 | 2 | IPR007266 | |
| Domain | zf-MYND | 3.08e-04 | 21 | 119 | 3 | PF01753 | |
| Domain | ZF_MYND_1 | 3.56e-04 | 22 | 119 | 3 | PS01360 | |
| Domain | Znf_MYND | 3.56e-04 | 22 | 119 | 3 | IPR002893 | |
| Domain | ZF_MYND_2 | 3.56e-04 | 22 | 119 | 3 | PS50865 | |
| Domain | PWWP | 4.07e-04 | 23 | 119 | 3 | PF00855 | |
| Domain | PWWP_dom | 4.07e-04 | 23 | 119 | 3 | IPR000313 | |
| Domain | PWWP | 4.63e-04 | 24 | 119 | 3 | PS50812 | |
| Domain | Chromo_domain | 4.63e-04 | 24 | 119 | 3 | IPR023780 | |
| Domain | Chromo | 5.89e-04 | 26 | 119 | 3 | PF00385 | |
| Domain | CHROMO_1 | 7.35e-04 | 28 | 119 | 3 | PS00598 | |
| Domain | CHROMO_2 | 7.35e-04 | 28 | 119 | 3 | PS50013 | |
| Domain | Znf_U1 | 8.17e-04 | 29 | 119 | 3 | IPR003604 | |
| Domain | ZnF_U1 | 8.17e-04 | 29 | 119 | 3 | SM00451 | |
| Domain | - | 1.06e-03 | 248 | 119 | 7 | 1.25.40.20 | |
| Domain | SNF2_N | 1.09e-03 | 32 | 119 | 3 | IPR000330 | |
| Domain | SNF2_N | 1.09e-03 | 32 | 119 | 3 | PF00176 | |
| Domain | Chromodomain-like | 1.09e-03 | 32 | 119 | 3 | IPR016197 | |
| Domain | ANK | 1.14e-03 | 251 | 119 | 7 | SM00248 | |
| Domain | ANK_REPEAT | 1.19e-03 | 253 | 119 | 7 | PS50088 | |
| Domain | Chromo/shadow_dom | 1.20e-03 | 33 | 119 | 3 | IPR000953 | |
| Domain | CHROMO | 1.20e-03 | 33 | 119 | 3 | SM00298 | |
| Domain | Ankyrin_rpt-contain_dom | 1.22e-03 | 254 | 119 | 7 | IPR020683 | |
| Domain | ANK_REP_REGION | 1.22e-03 | 254 | 119 | 7 | PS50297 | |
| Domain | Calx_beta | 1.41e-03 | 9 | 119 | 2 | IPR003644 | |
| Domain | Calx-beta | 1.41e-03 | 9 | 119 | 2 | PF03160 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 1.42e-03 | 35 | 119 | 3 | IPR002464 | |
| Domain | Ankyrin_rpt | 1.46e-03 | 262 | 119 | 7 | IPR002110 | |
| Domain | DEAH_ATP_HELICASE | 1.81e-03 | 38 | 119 | 3 | PS00690 | |
| Domain | Ank_2 | 2.56e-03 | 215 | 119 | 6 | PF12796 | |
| Domain | SET | 3.14e-03 | 46 | 119 | 3 | SM00317 | |
| Domain | Ank | 3.42e-03 | 228 | 119 | 6 | PF00023 | |
| Domain | EXOIII | 3.48e-03 | 14 | 119 | 2 | SM00479 | |
| Domain | Exonuclease_RNaseT/DNA_pol3 | 3.48e-03 | 14 | 119 | 2 | IPR013520 | |
| Domain | RNase_T | 3.48e-03 | 14 | 119 | 2 | PF00929 | |
| Domain | CNH | 3.48e-03 | 14 | 119 | 2 | SM00036 | |
| Domain | SET_dom | 3.97e-03 | 50 | 119 | 3 | IPR001214 | |
| Domain | SANT | 3.97e-03 | 50 | 119 | 3 | SM00717 | |
| Domain | SET | 3.97e-03 | 50 | 119 | 3 | PS50280 | |
| Domain | CNH | 4.00e-03 | 15 | 119 | 2 | PF00780 | |
| Domain | CNH | 4.00e-03 | 15 | 119 | 2 | PS50219 | |
| Domain | CNH_dom | 4.00e-03 | 15 | 119 | 2 | IPR001180 | |
| Domain | SANT/Myb | 4.44e-03 | 52 | 119 | 3 | IPR001005 | |
| Domain | ZnF_C2HC | 5.20e-03 | 55 | 119 | 3 | SM00343 | |
| Domain | Znf_CCHC | 5.20e-03 | 55 | 119 | 3 | IPR001878 | |
| Domain | AGC-kinase_C | 5.47e-03 | 56 | 119 | 3 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 5.47e-03 | 56 | 119 | 3 | PS51285 | |
| Domain | S_TK_X | 5.47e-03 | 56 | 119 | 3 | SM00133 | |
| Domain | ZF_MATRIN | 5.76e-03 | 18 | 119 | 2 | PS50171 | |
| Domain | Chromodomain_CS | 5.76e-03 | 18 | 119 | 2 | IPR023779 | |
| Domain | ARM-type_fold | 6.04e-03 | 339 | 119 | 7 | IPR016024 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | HNRNPDL ELOA RAD18 REXO4 HIVEP1 EP400 ZMYND8 CAST SLU7 MSL1 ZDBF2 CWC22 TRIP12 NCBP3 PCF11 CEP170 RIF1 NUTM2B ANKRD11 ZNF638 BOD1L1 MPHOSPH8 TOP2A AFF4 DNMT1 HDAC2 | 5.48e-16 | 954 | 124 | 26 | 36373674 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ELOA ZCCHC9 ZMYND11 RAD18 REXO4 HIVEP1 CHD2 MSL1 TRIP12 NCBP3 RLF RIF1 ZBTB21 BOD1L1 MPHOSPH8 CHD6 PRDM15 TOP2A AFF4 DNMT1 HDAC2 | 4.92e-15 | 608 | 124 | 21 | 36089195 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | ELOA REXO4 EP400 ZMYND8 SLU7 TRIP12 PCF11 RIF1 ZNF638 BOD1L1 TOP2A AFF4 DNMT1 | 3.19e-11 | 283 | 124 | 13 | 30585729 |
| Pubmed | MED6 ZCCHC9 REXO4 TENT4B CDC42BPA EP400 PPP1R12A ZMYND8 CHD2 MSL1 CIT RSRC1 DNAJC2 NGDN PCF11 INTS10 TOMM70 RIF1 PPP2R5C SPATS2L MACO1 ANKRD11 MPHOSPH8 CHD6 AFF4 | 9.94e-11 | 1497 | 124 | 25 | 31527615 | |
| Pubmed | SEMA4F ELOA EP400 MYCBP2 ERO1A DYNC2I1 ARHGEF18 ZDBF2 CEP170 MACO1 DIAPH1 ZNF638 BOD1L1 CHD6 CLSPN RWDD4 PDZRN3 DNMT1 | 1.40e-10 | 733 | 124 | 18 | 34672954 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | HNRNPDL MED6 RAD18 EP400 ZMYND8 CHD2 MSL1 CCDC12 TRIP12 RSRC1 NGDN INTS10 RIF1 PRDM11 LMO7 MACO1 ANKRD11 ZNF638 MPHOSPH8 CHD6 TOP2A DNMT1 HDAC2 | 1.87e-10 | 1294 | 124 | 23 | 30804502 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | SEMA4F ZCCHC9 ERO1B MYCBP2 ERO1A ELOVL5 DNAJB4 SLU7 CIT NGDN CEP170 TOMM70 SNRNP48 LMO7 MACO1 DNMT1 HDAC2 | 1.72e-09 | 754 | 124 | 17 | 33060197 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | HNRNPDL ELOA RAD18 HIVEP1 EP400 MYCBP2 ZMYND8 CAST TRIP12 REXO1 PCF11 RIF1 LMO7 ZBTB21 ZNF638 TOP2A DNMT1 | 2.55e-09 | 774 | 124 | 17 | 15302935 |
| Pubmed | HNRNPDL REXO4 TENT4B CDC42BPA ANK3 EP400 TRIP12 DNAH7 PCF11 RIF1 FAT1 ZNF638 PWWP3A MARVELD2 CLSPN ZMAT1 DNMT1 | 2.70e-09 | 777 | 124 | 17 | 35844135 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | HNRNPDL ELOA REXO4 TENT4B CWC22 TRIP12 NGDN RIF1 SPATS2L ZNF638 PWWP3A BOD1L1 MPHOSPH8 CLSPN TOP2A AFF4 DNMT1 HDAC2 | 1.53e-08 | 989 | 124 | 18 | 36424410 |
| Pubmed | ELOA MED6 ZMYND11 RAD18 EP400 ZMYND8 DNAJB4 CHD2 CCDC12 RIF1 ZBTB21 DIAPH1 UBE2S BOD1L1 MPHOSPH8 TOP2A DNMT1 HDAC2 | 2.24e-08 | 1014 | 124 | 18 | 32416067 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | HNRNPDL MED6 PPP1R12A CIR1 CCDC12 CWC22 TRIP12 RSRC1 DNAJC2 CEP170 ZNF638 MPHOSPH8 TOP2A DNMT1 HDAC2 | 3.33e-08 | 701 | 124 | 15 | 30196744 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | LCA5 ELOA PDE8A ANK3 TRAF3IP1 MYCBP2 PPP1R12A ELOVL5 DYNC2I1 DNAJB4 SMYD2 RSRC1 CEP170 NEK1 RIF1 PPP2R5C LMO7 ZBTB21 ZNF638 HDAC2 | 4.75e-08 | 1321 | 124 | 20 | 27173435 |
| Pubmed | REXO4 TENT4B CDC42BPA PPP1R12A ZMYND8 ELOVL5 CCDC12 TRIP12 RSRC1 NGDN PCF11 RIF1 SPATS2L LMO7 ZNF638 TOP2A | 6.25e-08 | 847 | 124 | 16 | 35850772 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CDC42BPA ANK3 MYCBP2 PPP1R12A CAST DYNC2I1 ARHGEF18 CHD2 CCDC12 SMOC2 RLF CEP170 ZNF608 SETBP1 ANKRD11 ZNF638 BOD1L1 CHD6 PRDM15 ZMAT1 AFF4 | 6.98e-08 | 1489 | 124 | 21 | 28611215 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | HIVEP1 ANK3 MYCBP2 TRIP12 NGDN PCF11 RLF CEP170 FAT1 LMO7 MACO1 | 7.70e-08 | 361 | 124 | 11 | 26167880 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | HIVEP1 CDC42BPA MYCBP2 PPP1R12A TRIP12 DNAH7 ENKD1 RSRC1 PIK3R4 CEP170 NEK1 LMO7 ZBTB21 ANKRD11 BOD1L1 DNMT1 | 7.81e-08 | 861 | 124 | 16 | 36931259 |
| Pubmed | MED6 EP400 MYCBP2 PPP1R12A MSL1 TRIP12 RLF CEP170 ZNF608 DIAPH1 ZNF638 MPHOSPH8 CHD6 PRDM15 | 8.27e-08 | 645 | 124 | 14 | 25281560 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | HNRNPDL ELOA ZCCHC9 REXO4 TENT4B MYCBP2 SLU7 TRIP12 NCBP3 NGDN PIK3R4 CEP170 RIF1 TOP2A DNMT1 | 9.34e-08 | 759 | 124 | 15 | 35915203 |
| Pubmed | ZMYND11 RAD18 EP400 PPP1R12A ZMYND8 ENKD1 CEP170 INTS10 FAT1 ZNF608 ANKRD2 ZBTB21 DIAPH1 CLSPN PDZRN3 TOP2A AFF4 HDAC2 | 9.44e-08 | 1116 | 124 | 18 | 31753913 | |
| Pubmed | HNRNPDL EP400 PPP1R12A ZMYND8 CAST RSRC1 DNAJC2 NCBP3 CEP170 RIF1 MPHOSPH8 HDAC2 | 1.37e-07 | 472 | 124 | 12 | 38943005 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ANK3 PPP1R12A ZMYND8 CHD2 TRIP12 NCBP3 PIK3R4 TRANK1 SARS1 LMO7 ANKRD11 HYDIN | 2.38e-07 | 497 | 124 | 12 | 36774506 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ELOA REXO4 CDC42BPA EP400 MYCBP2 ZMYND8 CHD2 CWC22 TRIP12 PCF11 CEP170 SNRNP48 ZNF638 MPHOSPH8 CHD6 AFF4 HDAC2 | 3.20e-07 | 1082 | 124 | 17 | 38697112 |
| Pubmed | HNRNPDL RAD18 ANK3 ERO1A PPP1R12A CAST SLU7 ARHGEF18 CHD2 TRIP12 PPP2R5C DIAPH1 ZNF638 BOD1L1 IL17RD ZMAT1 AFF4 | 3.29e-07 | 1084 | 124 | 17 | 11544199 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 3.42e-07 | 332 | 124 | 10 | 32786267 | |
| Pubmed | ANK3 EP400 MYCBP2 PPP1R12A CAST CEP170 NEK1 LMO7 BOD1L1 TOP2A DNMT1 HDAC2 | 6.81e-07 | 549 | 124 | 12 | 38280479 | |
| Pubmed | RAD18 REXO4 HIVEP1 CDC42BPA EP400 ZMYND8 SLU7 MSL1 CIT RSRC1 PCF11 RLF RIF1 FAT1 ZNF608 ZBTB21 ZNF638 CHD6 HDAC2 | 7.68e-07 | 1429 | 124 | 19 | 35140242 | |
| Pubmed | CYLC1 HNRNPDL ELOA PPP1R12A CHD2 MSL1 TRIP12 NGDN PCF11 SNRNP48 ZNF608 LMO7 ZBTB21 CC2D2A BOD1L1 MPHOSPH8 CHD6 TOP2A HDAC2 | 8.79e-07 | 1442 | 124 | 19 | 35575683 | |
| Pubmed | EP400 CHD2 CCDC12 TRIP12 NCBP3 ZNF638 BOD1L1 CHD6 HYDIN TOP2A DNMT1 | 1.03e-06 | 469 | 124 | 11 | 27634302 | |
| Pubmed | ELOA REXO4 CDC42BPA EP400 CHD2 MSL1 TRIP12 RSRC1 NCBP3 NGDN PCF11 CEP170 RIF1 SPATS2L LMO7 AFF4 DNMT1 HDAC2 | 1.85e-06 | 1371 | 124 | 18 | 36244648 | |
| Pubmed | HNRNPDL MED6 HIVEP1 EP400 MYCBP2 ZMYND8 SLU7 CCDC12 CIT PCF11 RLF CEP170 ZBTB21 TOP2A DNMT1 HDAC2 | 2.07e-06 | 1103 | 124 | 16 | 34189442 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | HNRNPDL ELOA REXO4 TENT4B PPP1R12A SLU7 CWC22 TRIP12 CIT DNAJC2 NGDN CEP170 SPATS2L LMO7 ZNF638 TOP2A DNMT1 | 2.48e-06 | 1257 | 124 | 17 | 36526897 |
| Pubmed | HIVEP1 MYCBP2 ZMYND8 ZDBF2 RLF NEK1 ZNF608 ZBTB21 CHD6 HDAC2 | 2.73e-06 | 418 | 124 | 10 | 34709266 | |
| Pubmed | REXO4 TRIP12 NCBP3 NGDN CEP170 SPATS2L ZNF638 MPHOSPH8 TOP2A | 3.20e-06 | 332 | 124 | 9 | 25693804 | |
| Pubmed | ANK3 TRAF3IP1 MYCBP2 ENPP2 ZMYND8 DYNC2I1 HUNK TRIP12 CIT ZNF365 SMYD2 PIK3R4 SNRNP48 LMO7 CHD6 AFF4 DNMT1 | 3.33e-06 | 1285 | 124 | 17 | 35914814 | |
| Pubmed | 3.66e-06 | 9 | 124 | 3 | 12773565 | ||
| Pubmed | 3.92e-06 | 116 | 124 | 6 | 30804394 | ||
| Pubmed | 5.70e-06 | 268 | 124 | 8 | 33640491 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ELOA EP400 PPP1R12A ZMYND8 CAST CEP170 NEK1 RIF1 ZBTB21 ZNF638 BOD1L1 TOP2A AFF4 DNMT1 | 6.51e-06 | 934 | 124 | 14 | 33916271 |
| Pubmed | Stage-specific induction of DNA methyltransferases in olfactory receptor neuron development. | 9.51e-06 | 12 | 124 | 3 | 16288735 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | HNRNPDL REXO4 MYCBP2 PPP1R12A CAST TRIP12 NGDN CEP170 SPATS2L GRK2 SARS1 LMO7 | 1.15e-05 | 724 | 124 | 12 | 36232890 |
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | 1.23e-05 | 298 | 124 | 8 | 32353859 | |
| Pubmed | The tyrosine phosphorylation of GRK2 is responsible for activated D2R-mediated insulin resistance. | 1.26e-05 | 2 | 124 | 2 | 36063601 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 26815200 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 37615725 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 37892234 | ||
| Pubmed | The dopamine D2 receptor can directly recruit and activate GRK2 without G protein activation. | 1.26e-05 | 2 | 124 | 2 | 29487132 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 19815545 | ||
| Pubmed | The cellular oxygen tension regulates expression of the endoplasmic oxidoreductase ERO1-Lalpha. | 1.26e-05 | 2 | 124 | 2 | 12752442 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 24924148 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 10818100 | ||
| Pubmed | Oxidative protein folding by an endoplasmic reticulum-localized peroxiredoxin. | 1.26e-05 | 2 | 124 | 2 | 21145486 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 25982413 | ||
| Pubmed | Glutathione limits Ero1-dependent oxidation in the endoplasmic reticulum. | 1.26e-05 | 2 | 124 | 2 | 15161913 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | HNRNPDL RAD18 TRAF3IP1 PPP1R12A DYNC2I1 DNAJB4 MSL1 CCDC12 CWC22 RSRC1 PCF11 CEP170 PPP2R5C TOP2A HDAC2 | 1.64e-05 | 1155 | 124 | 15 | 20360068 |
| Pubmed | HIVEP1 KIF16B ELOVL5 SLU7 CHD2 ZDBF2 SMOC2 DNAH7 NGDN CHD6 IL17RD | 1.89e-05 | 638 | 124 | 11 | 31182584 | |
| Pubmed | CDC42BPA EP400 KIF16B CWC22 PPP2R5C TRANK1 ZNF608 LMO7 SETBP1 ZBTB21 | 2.11e-05 | 529 | 124 | 10 | 14621295 | |
| Pubmed | 2.21e-05 | 157 | 124 | 6 | 30186101 | ||
| Pubmed | CDC42BPA ERO1B ANK3 MYCBP2 ERO1A KIF16B DNAJB4 SLU7 DNAJC2 NCBP3 PCF11 FAM204A SARS1 MACO1 ANKRD11 MARVELD2 DNMT1 | 2.22e-05 | 1487 | 124 | 17 | 33957083 | |
| Pubmed | ZCCHC9 TENT4B MYCBP2 ENKD1 TOMM70 NEK1 FAT1 SPATS2L LMO7 DNMT1 | 2.25e-05 | 533 | 124 | 10 | 25544563 | |
| Pubmed | ELOA PPP1R12A ZMYND8 CWC22 CEP170 INTS10 PPP2R5C DIAPH1 TOP2A HDAC2 | 3.42e-05 | 560 | 124 | 10 | 35241646 | |
| Pubmed | 3.47e-05 | 18 | 124 | 3 | 24025402 | ||
| Pubmed | 3.52e-05 | 103 | 124 | 5 | 32744500 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 20668165 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 25217958 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 35347798 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 20807772 | ||
| Pubmed | The clinical phenotype of YWHAE-NUTM2B/E positive pediatric clear cell sarcoma of the kidney. | 3.77e-05 | 3 | 124 | 2 | 26542179 | |
| Pubmed | Lifetime imaging of a fluorescent protein sensor reveals surprising stability of ER thiol redox. | 3.77e-05 | 3 | 124 | 2 | 23589496 | |
| Pubmed | Manipulation of oxidative protein folding and PDI redox state in mammalian cells. | 3.77e-05 | 3 | 124 | 2 | 11707400 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 23082996 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 22981861 | ||
| Pubmed | Epigenetic modification of intestinal smooth muscle cell phenotype during proliferation. | 3.77e-05 | 3 | 124 | 2 | 30110565 | |
| Pubmed | 4.04e-05 | 106 | 124 | 5 | 18654987 | ||
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | HNRNPDL ELOA REXO4 ERO1B ERO1A CIR1 TRIP12 TOMM70 PPP2R5C SPATS2L SARS1 | 4.62e-05 | 704 | 124 | 11 | 32994395 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | RAD18 TRIP12 PIK3R4 PCF11 RIF1 LMO7 DIAPH1 ZNF638 UBE2S TOP2A | 4.72e-05 | 582 | 124 | 10 | 20467437 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HNRNPDL REXO4 HIVEP1 TENT4B ERO1A CWC22 PIK3R4 TOMM70 RIF1 SARS1 DIAPH1 CC2D2A BOD1L1 MPHOSPH8 TOP2A DNMT1 | 4.89e-05 | 1425 | 124 | 16 | 30948266 |
| Pubmed | ZMYND11 HIVEP1 ANK3 MYCBP2 ZMYND8 TRIP12 RLF MACO1 DIAPH1 CHD6 | 5.37e-05 | 591 | 124 | 10 | 15231748 | |
| Pubmed | 5.72e-05 | 272 | 124 | 7 | 31010829 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 5.73e-05 | 370 | 124 | 8 | 22922362 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | EP400 PPP1R12A ZMYND8 SLU7 TRIP12 SMYD2 TOMM70 RIF1 ZBTB21 PRDM15 TOP2A HDAC2 | 5.93e-05 | 857 | 124 | 12 | 25609649 |
| Pubmed | MYCBP2 SPCS1 ERO1A PPP1R12A CIR1 DNAJB4 TRIP12 NGDN CEP170 FAT1 SPATS2L DIAPH1 UBE2S BOD1L1 DNMT1 | 6.15e-05 | 1297 | 124 | 15 | 33545068 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | HNRNPDL ELOA REXO4 ZMYND8 SLU7 NCBP3 NGDN ZNF638 TOP2A HDAC2 | 6.52e-05 | 605 | 124 | 10 | 28977666 |
| Pubmed | 7.18e-05 | 282 | 124 | 7 | 23667531 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | HNRNPDL EP400 ZMYND8 CHD2 CCDC12 CWC22 TRIP12 RSRC1 NGDN DIAPH1 UBE2S CHD6 TOP2A DNMT1 HDAC2 | 7.36e-05 | 1318 | 124 | 15 | 30463901 |
| Pubmed | The splicing regulator SLU7 is required to preserve DNMT1 protein stability and DNA methylation. | 7.53e-05 | 4 | 124 | 2 | 34331453 | |
| Pubmed | BS69 is involved in cellular senescence through the p53-p21Cip1 pathway. | 7.53e-05 | 4 | 124 | 2 | 17721438 | |
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 20308425 | ||
| Pubmed | ERp44, a novel endoplasmic reticulum folding assistant of the thioredoxin family. | 7.53e-05 | 4 | 124 | 2 | 11847130 | |
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 21457715 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 16677073 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 27911814 | ||
| Pubmed | Cdc42-MRCK and Rho-ROCK signalling cooperate in myosin phosphorylation and cell invasion. | 7.53e-05 | 4 | 124 | 2 | 15723050 | |
| Pubmed | Antigens recognized by autologous antibody in patients with renal-cell carcinoma. | 7.79e-05 | 63 | 124 | 4 | 10508479 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | HNRNPDL EP400 MYCBP2 TRIP12 CIT NCBP3 CEP170 RIF1 LMO7 ZBTB21 ZNF638 TOP2A HDAC2 | 7.80e-05 | 1024 | 124 | 13 | 24711643 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 8.87e-05 | 394 | 124 | 8 | 27248496 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HNRNPDL REXO4 EP400 MYCBP2 SLU7 CHD2 TRIP12 NGDN PIK3R4 RLF RIF1 DIAPH1 ZNF638 TOP2A DNMT1 | 9.84e-05 | 1353 | 124 | 15 | 29467282 |
| Pubmed | Elongin A regulates transcription in vivo through enhanced RNA polymerase processivity. | 1.08e-04 | 26 | 124 | 3 | 33298525 | |
| Pubmed | 1.11e-04 | 210 | 124 | 6 | 16565220 | ||
| Pubmed | 1.25e-04 | 5 | 124 | 2 | 37373182 | ||
| Interaction | ZNF330 interactions | HNRNPDL ELOA RAD18 REXO4 TENT4B ZMYND8 SLU7 MSL1 TRIP12 NCBP3 RLF ZBTB21 ANKRD11 MPHOSPH8 PRDM15 RWDD4 TOP2A AFF4 DNMT1 | 2.47e-11 | 446 | 122 | 19 | int:ZNF330 |
| Interaction | SMC5 interactions | HNRNPDL ELOA RAD18 REXO4 HIVEP1 EP400 ZMYND8 CAST SLU7 MSL1 ZDBF2 CWC22 TRIP12 NCBP3 PCF11 CEP170 RIF1 NUTM2B ANKRD11 ZNF638 BOD1L1 MPHOSPH8 TOP2A AFF4 DNMT1 HDAC2 | 2.28e-10 | 1000 | 122 | 26 | int:SMC5 |
| Interaction | H3C3 interactions | ELOA ZCCHC9 RAD18 REXO4 HIVEP1 MSL1 TRIP12 NCBP3 RLF RIF1 BOD1L1 MPHOSPH8 CHD6 PRDM15 TOP2A AFF4 DNMT1 HDAC2 | 1.11e-09 | 495 | 122 | 18 | int:H3C3 |
| Interaction | TERF2IP interactions | ELOA RAD18 HIVEP1 EP400 ZMYND8 SLU7 TRIP12 PCF11 RIF1 ZNF608 ZBTB21 ANKRD11 ZNF638 BOD1L1 CLSPN TOP2A AFF4 DNMT1 | 6.11e-09 | 552 | 122 | 18 | int:TERF2IP |
| Interaction | NUP43 interactions | REXO4 HIVEP1 EP400 PPP1R12A ZMYND8 MSL1 ZDBF2 CWC22 TRIP12 CIT NCBP3 RLF RIF1 ZNF608 ANKRD11 BOD1L1 CHD6 TOP2A HDAC2 | 6.94e-09 | 625 | 122 | 19 | int:NUP43 |
| Interaction | H3-3A interactions | ELOA ZMYND11 RAD18 REXO4 HIVEP1 DYNC2I1 CHD2 MSL1 TRIP12 NCBP3 RLF RIF1 ZBTB21 BOD1L1 MPHOSPH8 PRDM15 TOP2A AFF4 DNMT1 HDAC2 | 2.35e-08 | 749 | 122 | 20 | int:H3-3A |
| Interaction | SRPK2 interactions | LCA5 RAD18 REXO4 HIVEP1 ANK3 MYCBP2 CHD2 ZMAT4 TRIP12 RSRC1 DNAJC2 NCBP3 NGDN PCF11 CEP170 LMO7 MACO1 ZNF638 TOP2A | 6.18e-08 | 717 | 122 | 19 | int:SRPK2 |
| Interaction | CBX3 interactions | HNRNPDL ELOA RAD18 REXO4 EP400 PPP1R12A ZMYND8 MSL1 TRIP12 CIT RLF RIF1 ZBTB21 DIAPH1 CLSPN TOP2A DNMT1 HDAC2 | 6.75e-08 | 646 | 122 | 18 | int:CBX3 |
| Interaction | SSRP1 interactions | HNRNPDL ELOA RAD18 ZMYND8 CHD2 CIT REXO1 RSRC1 PCF11 RLF INTS10 RIF1 RHOV ANKRD11 ZNF638 MPHOSPH8 CLSPN TOP2A | 1.62e-07 | 685 | 122 | 18 | int:SSRP1 |
| Interaction | PARP1 interactions | ELOA MED6 RAD18 REXO4 HIVEP1 TENT4B EP400 MYCBP2 SLU7 MSL1 NLRP2 TRIP12 ZNF365 PIK3R4 RLF CEP170 LMO7 ZBTB21 UBE2S CHD6 CLSPN TOP2A AFF4 DNMT1 HDAC2 | 2.68e-07 | 1316 | 122 | 25 | int:PARP1 |
| Interaction | POLR1G interactions | ELOA REXO4 TENT4B EP400 ZMYND8 SLU7 CHD2 TRIP12 CIT NCBP3 CRCP ANKRD11 CLSPN TOP2A AFF4 | 2.74e-07 | 489 | 122 | 15 | int:POLR1G |
| Interaction | H2BC8 interactions | ELOA RAD18 REXO4 EP400 ZMYND8 SLU7 MSL1 TRIP12 NCBP3 RLF RIF1 MPHOSPH8 CHD6 PRDM15 TOP2A DNMT1 | 4.04e-07 | 576 | 122 | 16 | int:H2BC8 |
| Interaction | SNRNP40 interactions | HNRNPDL RAD18 REXO4 HIVEP1 TENT4B EP400 SLU7 ZDBF2 CCDC12 CWC22 CIT RSRC1 ZNF608 ZBTB21 TOP2A HDAC2 | 1.52e-06 | 637 | 122 | 16 | int:SNRNP40 |
| Interaction | H3C1 interactions | ELOA ZMYND11 RAD18 REXO4 ANK3 ZMYND8 CAST MSL1 TRIP12 RLF RIF1 SPATS2L SARS1 ZNF638 MPHOSPH8 TOP2A AFF4 DNMT1 HDAC2 | 1.99e-06 | 901 | 122 | 19 | int:H3C1 |
| Interaction | PPIA interactions | HNRNPDL ANK3 EP400 PPP1R12A ZMYND8 CAST CIT RSRC1 DNAJC2 NCBP3 CEP170 RIF1 RHOV MACO1 MPHOSPH8 FKBP2 TOP2A HDAC2 | 6.58e-06 | 888 | 122 | 18 | int:PPIA |
| Interaction | MEN1 interactions | REXO4 TENT4B CDC42BPA EP400 ZMYND8 ELOVL5 CCDC12 TRIP12 NCBP3 PCF11 RIF1 ZNF608 LMO7 SETBP1 ZNF638 BOD1L1 TOP2A AFF4 HDAC2 | 1.33e-05 | 1029 | 122 | 19 | int:MEN1 |
| Interaction | CENPA interactions | RAD18 REXO4 HIVEP1 TRIP12 NCBP3 RLF DIAPH1 ANKRD11 CHD6 TOP2A DNMT1 | 1.86e-05 | 377 | 122 | 11 | int:CENPA |
| Interaction | FBXO22 interactions | ANK3 PPP1R12A ZMYND8 CHD2 TRIP12 CIT NCBP3 PIK3R4 TRANK1 SARS1 LMO7 ANKRD11 HYDIN | 2.43e-05 | 540 | 122 | 13 | int:FBXO22 |
| Interaction | FGFBP1 interactions | 2.70e-05 | 257 | 122 | 9 | int:FGFBP1 | |
| Interaction | ARL4D interactions | 3.03e-05 | 146 | 122 | 7 | int:ARL4D | |
| Interaction | COIL interactions | ELOA RAD18 HIVEP1 TENT4B SLU7 CIT NCBP3 RLF ZBTB21 ANKRD11 CHD6 TOP2A AFF4 | 3.05e-05 | 552 | 122 | 13 | int:COIL |
| Interaction | YWHAH interactions | LCA5 HIVEP1 CDC42BPA MYCBP2 PPP1R12A CWC22 TRIP12 DNAH7 ENKD1 PIK3R4 CEP170 NEK1 LMO7 ZBTB21 ANKRD11 ZNF638 CC2D2A BOD1L1 DNMT1 | 3.44e-05 | 1102 | 122 | 19 | int:YWHAH |
| Interaction | DDX23 interactions | ELOA RAD18 REXO4 SLU7 CHD2 CWC22 CIT RSRC1 ANKRD11 ZNF638 TOP2A AFF4 | 3.53e-05 | 480 | 122 | 12 | int:DDX23 |
| Interaction | SOX2 interactions | ELOA ZCCHC9 REXO4 HIVEP1 CDC42BPA EP400 PPP1R12A ZMYND8 MSL1 ZDBF2 TRIP12 CIT RLF CEP170 PPP2R5C SPATS2L ZNF608 MACO1 ZNF638 BOD1L1 CHD6 HDAC2 | 4.02e-05 | 1422 | 122 | 22 | int:SOX2 |
| Interaction | YWHAG interactions | LCA5 HIVEP1 CDC42BPA MYCBP2 PPP1R12A CWC22 TRIP12 FAM13B DNAH7 ENKD1 RSRC1 PIK3R4 CEP170 NEK1 LMO7 ZBTB21 ANKRD11 ZNF638 BOD1L1 DNMT1 | 5.84e-05 | 1248 | 122 | 20 | int:YWHAG |
| Interaction | SUMO2 interactions | EP400 ZMYND8 CAST TRIP12 RIF1 SARS1 LMO7 ZBTB21 ZNF638 BOD1L1 TOP2A DNMT1 HDAC2 | 6.14e-05 | 591 | 122 | 13 | int:SUMO2 |
| Interaction | YWHAE interactions | LCA5 ELOA RAD18 HIVEP1 CDC42BPA MYCBP2 PPP1R12A TRIP12 FAM13B ENKD1 PIK3R4 CEP170 NEK1 SLC8A3 PPP2R5C LMO7 ZBTB21 ZNF638 TOP2A DNMT1 | 6.38e-05 | 1256 | 122 | 20 | int:YWHAE |
| Interaction | H2BC21 interactions | CYLC1 EP400 ZMYND8 SLU7 MSL1 TRIP12 RSRC1 RLF TOMM70 RIF1 ZNF638 MPHOSPH8 TOP2A HDAC2 | 8.24e-05 | 696 | 122 | 14 | int:H2BC21 |
| Interaction | HECTD1 interactions | HNRNPDL ELOA MED6 ZCCHC9 REXO4 TENT4B MYCBP2 SLU7 TRIP12 NCBP3 NGDN PIK3R4 CEP170 RIF1 ANKRD11 TOP2A DNMT1 | 9.06e-05 | 984 | 122 | 17 | int:HECTD1 |
| Interaction | SNRNP48 interactions | 9.87e-05 | 40 | 122 | 4 | int:SNRNP48 | |
| Interaction | DOT1L interactions | REXO4 TENT4B CDC42BPA PPP1R12A ZMYND8 CCDC12 TRIP12 RSRC1 NGDN PCF11 RIF1 SPATS2L LMO7 ZNF638 TOP2A | 1.09e-04 | 807 | 122 | 15 | int:DOT1L |
| Interaction | H1-7 interactions | 1.10e-04 | 179 | 122 | 7 | int:H1-7 | |
| Interaction | SMARCA4 interactions | MED6 ZMYND11 RAD18 TENT4B EP400 PPP1R12A ZMYND8 CIT MYOCD TOP2A HDAC2 | 1.17e-04 | 462 | 122 | 11 | int:SMARCA4 |
| Interaction | YWHAZ interactions | LCA5 ELOA HIVEP1 CDC42BPA MYCBP2 ERO1A PPP1R12A DNAJB4 ARHGEF18 TRIP12 FAM13B CEP170 NEK1 PPP2R5C LMO7 MACO1 ZBTB21 ZNF638 DNMT1 HDAC2 | 1.25e-04 | 1319 | 122 | 20 | int:YWHAZ |
| Interaction | DHX40 interactions | 1.39e-04 | 249 | 122 | 8 | int:DHX40 | |
| Interaction | XRCC6 interactions | ELOA REXO4 EP400 ZMYND8 SLU7 TRIP12 CIT PCF11 RIF1 DIAPH1 ZNF638 UBE2S BOD1L1 TOP2A AFF4 DNMT1 | 1.52e-04 | 928 | 122 | 16 | int:XRCC6 |
| Interaction | SNRPA interactions | HNRNPDL RAD18 SLU7 CCDC12 CWC22 CIT RSRC1 NCBP3 PCF11 ZNF638 TOP2A | 1.69e-04 | 482 | 122 | 11 | int:SNRPA |
| Interaction | SNW1 interactions | RAD18 CIR1 SLU7 MSL1 CCDC12 TRIP12 CIT PIK3R4 PCF11 RIF1 SARS1 DIAPH1 ZNF638 HDAC2 | 1.73e-04 | 747 | 122 | 14 | int:SNW1 |
| Interaction | KDM1A interactions | HIVEP1 EP400 MYCBP2 PPP1R12A ZMYND8 SLU7 ZDBF2 CIT RLF FAM204A NEK1 ZNF608 ZBTB21 CHD6 DNMT1 HDAC2 | 1.78e-04 | 941 | 122 | 16 | int:KDM1A |
| Interaction | SUPT5H interactions | 1.90e-04 | 408 | 122 | 10 | int:SUPT5H | |
| Interaction | NHLH1 interactions | 1.96e-04 | 88 | 122 | 5 | int:NHLH1 | |
| Interaction | RBM4B interactions | 1.97e-04 | 262 | 122 | 8 | int:RBM4B | |
| Interaction | ATG16L1 interactions | HNRNPDL MED6 ANK3 MYCBP2 PPP1R12A KIF16B CIR1 CCDC12 CWC22 TRIP12 RSRC1 DNAJC2 CEP170 ZNF638 MPHOSPH8 TOP2A DNMT1 HDAC2 | 2.15e-04 | 1161 | 122 | 18 | int:ATG16L1 |
| Interaction | PEA15 interactions | 2.18e-04 | 90 | 122 | 5 | int:PEA15 | |
| Interaction | APEX1 interactions | ELOA ZFAND2A RAD18 REXO4 HIVEP1 EP400 PPP1R12A ZMYND8 SLU7 TRIP12 ENKD1 RLF METTL1 RIF1 ANKRD11 ZNF638 AFF4 DNMT1 HDAC2 | 2.25e-04 | 1271 | 122 | 19 | int:APEX1 |
| Interaction | NIFK interactions | ELOA ZCCHC9 REXO4 TENT4B CIT NCBP3 SPATS2L ANKRD11 FKBP2 AFF4 | 2.95e-04 | 431 | 122 | 10 | int:NIFK |
| Interaction | ILF3 interactions | HNRNPDL REXO4 PPP1R12A CAST TRIP12 CIT RSRC1 DNAJC2 SPATS2L LMO7 DIAPH1 MPHOSPH8 PRDM15 TOP2A HDAC2 | 3.39e-04 | 896 | 122 | 15 | int:ILF3 |
| Interaction | HDAC1 interactions | ZMYND11 HIVEP1 CDC42BPA EP400 MYCBP2 ZMYND8 ZDBF2 CIT RLF NEK1 ZNF608 LMO7 ZBTB21 ZNF638 TOP2A DNMT1 HDAC2 | 3.69e-04 | 1108 | 122 | 17 | int:HDAC1 |
| Interaction | RPS24 interactions | HNRNPDL ELOA ZCCHC9 REXO4 ZMYND8 CIT DNAJC2 NGDN SPATS2L ANKRD11 TOP2A | 3.74e-04 | 529 | 122 | 11 | int:RPS24 |
| Interaction | H2BC9 interactions | CYLC1 HIVEP1 TRAF3IP1 ENPP2 TOMM70 SETBP1 DIAPH1 TOP2A AFF4 DNMT1 | 3.86e-04 | 446 | 122 | 10 | int:H2BC9 |
| Interaction | H1-3 interactions | 3.99e-04 | 291 | 122 | 8 | int:H1-3 | |
| Interaction | DHX8 interactions | 4.08e-04 | 292 | 122 | 8 | int:DHX8 | |
| Interaction | CDK8 interactions | 4.11e-04 | 222 | 122 | 7 | int:CDK8 | |
| Interaction | CSNK2B interactions | RAD18 CDC42BPA EP400 ZMYND8 RSRC1 NGDN CEP170 GRK2 ANKRD11 CLSPN TOP2A DNMT1 | 4.14e-04 | 625 | 122 | 12 | int:CSNK2B |
| Interaction | SIRT6 interactions | EP400 MYCBP2 DYNC2I1 ZDBF2 NLRP2 TRIP12 PCF11 CEP170 METTL1 FAT1 TOP2A HDAC2 | 4.32e-04 | 628 | 122 | 12 | int:SIRT6 |
| Interaction | H2AZ1 interactions | 4.32e-04 | 371 | 122 | 9 | int:H2AZ1 | |
| GeneFamily | Ankyrin repeat domain containing | 4.53e-05 | 242 | 71 | 7 | 403 | |
| GeneFamily | Zinc fingers MYND-type | 7.34e-05 | 21 | 71 | 3 | 87 | |
| GeneFamily | PWWP domain containing | 8.47e-05 | 22 | 71 | 3 | 1147 | |
| GeneFamily | Zinc fingers CCCH-type|Zinc fingers matrin-type | 1.51e-04 | 5 | 71 | 2 | 84 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.18e-03 | 53 | 71 | 3 | 532 | |
| GeneFamily | Exonucleases | 1.76e-03 | 16 | 71 | 2 | 544 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 1.99e-03 | 17 | 71 | 2 | 1197 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | ZCCHC9 RAD18 CDC42BPA MYCBP2 ENPP2 KIF16B CAST DYNC2I1 SLU7 FAM13B RLF CEP170 NEK1 RIF1 BTBD7 ZNF638 MPHOSPH8 HDAC2 | 1.57e-09 | 656 | 122 | 18 | M18979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | HNRNPDL ZMYND11 HIVEP1 CDC42BPA PDE8A MYCBP2 PPP1R12A ZMYND8 TRIP12 DNAJC2 PIK3R4 PCF11 RLF CEP170 NEK1 RIF1 FAT1 PPP2R5C ZNF638 TOP2A | 2.80e-09 | 856 | 122 | 20 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | HNRNPDL ZMYND11 HIVEP1 CDC42BPA PDE8A MYCBP2 PPP1R12A ZMYND8 TRIP12 CEP170 FAT1 PPP2R5C ZNF638 TOP2A | 3.86e-08 | 466 | 122 | 14 | M13522 |
| Coexpression | GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_UP | 4.41e-06 | 199 | 122 | 8 | M10018 | |
| Coexpression | GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_DN | 4.41e-06 | 199 | 122 | 8 | M6172 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_T_CELL_AGEING | EP400 MYCBP2 PPP1R12A CCDC12 CIT NGDN FAM204A SNRNP48 ANKRD11 BOD1L1 FKBP2 | 7.73e-06 | 445 | 122 | 11 | MM3853 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.18e-05 | 300 | 122 | 9 | M8702 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | HIVEP1 TENT4B ERO1B ELOVL5 CIR1 CHD2 ZDBF2 DNAJC2 RIF1 PPP2R5C GRK2 BOD1L1 AFF4 | 1.77e-05 | 680 | 122 | 13 | M41089 |
| Coexpression | PUJANA_ATM_PCC_NETWORK | SEMA4F MED6 EP400 CAST ELOVL5 CIR1 ARHGEF18 DNAJC2 NGDN PCF11 INTS10 RIF1 PPP2R5C GRK2 CRCP DIAPH1 UBE2S TOP2A DNMT1 | 2.39e-05 | 1394 | 122 | 19 | M9585 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP | 3.69e-05 | 195 | 122 | 7 | M1110 | |
| Coexpression | GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_UP | 4.33e-05 | 200 | 122 | 7 | M4884 | |
| Coexpression | GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_UP | 4.33e-05 | 200 | 122 | 7 | M8495 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 5.24e-05 | 363 | 122 | 9 | M41103 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP | 5.38e-05 | 207 | 122 | 7 | MM475 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | HNRNPDL EP400 MYCBP2 PPP1R12A ELOVL5 CHD2 TRIP12 FAM13B PCF11 RIF1 PPP2R5C TRANK1 GRK2 DIAPH1 ANKRD11 ZNF638 BOD1L1 MPHOSPH8 DNMT1 | 6.00e-05 | 1492 | 122 | 19 | M40023 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | ZMYND8 ELOVL5 DYNC2I1 SMOC2 RSRC1 DNAJC2 MACO1 MYOCD RWDD4 DNMT1 | 6.82e-05 | 467 | 122 | 10 | M1347 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | RAD18 GAP43 CIT ENKD1 RIF1 PPP2R5C SPATS2L CLSPN PDZRN3 TOP2A DNMT1 | 8.41e-05 | 578 | 122 | 11 | M2368 |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | HNRNPDL ZMYND11 ZMYND8 ELOVL5 TRIP12 PCF11 FAT1 ZNF638 TOP2A DNMT1 | 8.70e-05 | 481 | 122 | 10 | M3898 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | ZMYND8 ELOVL5 DYNC2I1 SMOC2 RSRC1 DNAJC2 MACO1 MYOCD RWDD4 DNMT1 | 9.16e-05 | 484 | 122 | 10 | MM999 |
| Coexpression | KIM_MYC_AMPLIFICATION_TARGETS_DN | 9.67e-05 | 98 | 122 | 5 | M6319 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | RAD18 GAP43 CIT ENKD1 RIF1 PPP2R5C SPATS2L CLSPN PDZRN3 TOP2A DNMT1 | 1.12e-04 | 597 | 122 | 11 | MM1309 |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN | 1.30e-04 | 166 | 122 | 6 | M8129 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | MED6 CAST CWC22 RSRC1 RLF TOMM70 RIF1 UBE2S BOD1L1 TOP2A AFF4 DNMT1 | 1.41e-04 | 721 | 122 | 12 | M10237 |
| Coexpression | GSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN | 1.48e-04 | 170 | 122 | 6 | M8188 | |
| Coexpression | GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 1.79e-04 | 176 | 122 | 6 | M9137 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | 2.02e-04 | 434 | 122 | 9 | M15150 | |
| Coexpression | BENPORATH_CYCLING_GENES | RAD18 MYCBP2 DNAJB4 NLRP2 CIT PCF11 BMP2 TOMM70 UBE2S CLSPN TOP2A | 2.28e-04 | 648 | 122 | 11 | M8156 |
| Coexpression | FAN_OVARY_CL11_MURAL_GRANULOSA_CELL | HNRNPDL ZFAND2A ELOVL5 DNAJB4 FAM204A ANKRD11 UBE2S AFF4 HDAC2 | 2.39e-04 | 444 | 122 | 9 | M41713 |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | 2.55e-04 | 448 | 122 | 9 | MM1044 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN | 2.63e-04 | 189 | 122 | 6 | M8275 | |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | 2.63e-04 | 189 | 122 | 6 | M3112 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_A | 3.02e-04 | 194 | 122 | 6 | M2517 | |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN | 3.02e-04 | 194 | 122 | 6 | M7306 | |
| Coexpression | GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_UP | 3.19e-04 | 196 | 122 | 6 | M10014 | |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP | HNRNPDL ZMYND11 CDC42BPA ANK3 ENPP2 ELOVL5 ARHGEF18 TOMM70 FAT1 PPP2R5C | 3.32e-04 | 568 | 122 | 10 | M4023 |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN | 3.37e-04 | 198 | 122 | 6 | M6104 | |
| Coexpression | GSE14350_TREG_VS_TEFF_UP | 3.46e-04 | 199 | 122 | 6 | M3417 | |
| Coexpression | GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_DN | 3.46e-04 | 199 | 122 | 6 | M6157 | |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | 3.46e-04 | 199 | 122 | 6 | M9124 | |
| Coexpression | GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_DN | 3.55e-04 | 200 | 122 | 6 | M5096 | |
| Coexpression | GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP | 3.55e-04 | 200 | 122 | 6 | M6477 | |
| Coexpression | GSE411_WT_VS_SOCS3_KO_MACROPHAGE_DN | 3.55e-04 | 200 | 122 | 6 | M5991 | |
| Coexpression | GSE8835_CD4_VS_CD8_TCELL_UP | 3.55e-04 | 200 | 122 | 6 | M6254 | |
| Coexpression | GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_UP | 3.55e-04 | 200 | 122 | 6 | M4590 | |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_BCELL_IFNAR_KO_UP | 3.55e-04 | 200 | 122 | 6 | M9994 | |
| Coexpression | GSE7831_CPG_VS_INFLUENZA_STIM_PDC_4H_UP | 3.55e-04 | 200 | 122 | 6 | M6958 | |
| Coexpression | GSE6674_CPG_VS_CPG_AND_ANTI_IGM_STIM_BCELL_DN | 3.55e-04 | 200 | 122 | 6 | M6941 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | 3.61e-04 | 574 | 122 | 10 | M39056 | |
| Coexpression | MENON_FETAL_KIDNEY_4_PODOCYTES | 4.16e-04 | 206 | 122 | 6 | M39254 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | ZDBF2 CIT DNAJC2 PCF11 RLF RIF1 SNRNP48 MACO1 ANKRD11 ZNF638 MPHOSPH8 CLSPN DNMT1 | 1.10e-05 | 532 | 121 | 13 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | ANO4 LCA5 SEMA4F RAD18 ANK3 SPCS1 LIX1L MSL1 HUNK SMOC2 TRIP12 FREM1 INTS10 TOMM70 SNRNP48 ZBTB21 | 1.69e-05 | 819 | 121 | 16 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ELOA TRAF3IP1 CHD2 ZDBF2 CIT DNAJC2 NEK1 RIF1 PPP2R5C BTBD7 SETBP1 CC2D2A BOD1L1 MPHOSPH8 CLSPN AFF4 | 2.02e-05 | 831 | 121 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | TRAF3IP1 PPP1R12A CIR1 DYNC2I1 SLU7 CHD2 CIT CEP170 NEK1 RIF1 PRDM11 BOD1L1 CLSPN | 6.26e-05 | 629 | 121 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000 | SEMA4F SPCS1 PPP1R12A DNAJB4 LIX1L HUNK TRIP12 DNAJC2 CEP170 SPATS2L ZBTB21 MYOCD ZMAT1 RWDD4 PDZRN3 | 7.24e-05 | 826 | 121 | 15 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | TRAF3IP1 CIR1 CIT DNAJC2 PCF11 RLF RIF1 SNRNP48 ANKRD11 ZNF638 CLSPN | 7.81e-05 | 469 | 121 | 11 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | MED6 ZCCHC9 RAD18 TENT4B TRAF3IP1 DYNC2I1 ZDBF2 CIT RSRC1 DNAJC2 RIF1 SNRNP48 RHOV SETBP1 BOD1L1 MPHOSPH8 CLSPN TOP2A DNMT1 | 8.89e-05 | 1257 | 121 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | HIVEP1 TRAF3IP1 MYCBP2 PPP1R12A CIR1 SLU7 CHD2 RSRC1 PIK3R4 CEP170 NEK1 TOP2A | 9.26e-05 | 564 | 121 | 12 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 9.63e-05 | 186 | 121 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.17e-04 | 192 | 121 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.77e-04 | 349 | 121 | 9 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.87e-04 | 276 | 121 | 8 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000_k3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | MED6 ZCCHC9 RAD18 TENT4B TRAF3IP1 DYNC2I1 ZDBF2 CWC22 CIT RSRC1 DNAJC2 RIF1 SNRNP48 RHOV SETBP1 BOD1L1 MPHOSPH8 CLSPN TOP2A DNMT1 | 2.13e-04 | 1459 | 121 | 20 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | ZCCHC9 PDE8A ANK3 GAP43 ENPP2 DYNC2I1 DNAJB4 ZMAT4 ZDBF2 CWC22 CIT RSRC1 DNAJC2 RIF1 RHOV PWWP3A BOD1L1 CLSPN TOP2A HDAC2 | 2.31e-04 | 1468 | 121 | 20 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.49e-04 | 288 | 121 | 8 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.54e-04 | 230 | 121 | 7 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 3.73e-04 | 232 | 121 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | CIR1 DYNC2I1 CHD2 DNAJC2 ZNF638 ANKRD18A BOD1L1 MPHOSPH8 CLSPN FKBP2 TOP2A DNMT1 | 3.68e-13 | 197 | 124 | 12 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 9.03e-08 | 199 | 124 | 8 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 9.03e-08 | 199 | 124 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.90e-07 | 185 | 124 | 7 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 8.90e-07 | 185 | 124 | 7 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.91e-07 | 188 | 124 | 7 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-06 | 189 | 124 | 7 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.10e-06 | 191 | 124 | 7 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.14e-06 | 192 | 124 | 7 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.27e-06 | 195 | 124 | 7 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.50e-06 | 200 | 124 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.50e-06 | 200 | 124 | 7 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 2.48e-06 | 138 | 124 | 6 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.43e-06 | 167 | 124 | 6 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.51e-06 | 171 | 124 | 6 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-05 | 180 | 124 | 6 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.18e-05 | 181 | 124 | 6 | 7e3bcfa2ba5b98a7df5854aa6e7a31e9a71faa8a | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 182 | 124 | 6 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.29e-05 | 184 | 124 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.33e-05 | 185 | 124 | 6 | a6cd90f8f30c7bdf66958cf403e73c193aa32f5e | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-pericyte_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.33e-05 | 185 | 124 | 6 | 5053f932e2adfcf4d6faaecff2999ac53d8d7aa5 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.37e-05 | 186 | 124 | 6 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.46e-05 | 188 | 124 | 6 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 189 | 124 | 6 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.50e-05 | 189 | 124 | 6 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 1.64e-05 | 192 | 124 | 6 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.64e-05 | 192 | 124 | 6 | 2cc712186e37fb21a964c032765c36a8b4a852cf | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-05 | 192 | 124 | 6 | 1b6cac8156e608061e1405e36e18d185b6fa8f6f | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.69e-05 | 193 | 124 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.69e-05 | 193 | 124 | 6 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.69e-05 | 193 | 124 | 6 | cf3cbf79ccd34ddcf06ec6194a18a7afd7f91f39 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-05 | 194 | 124 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.79e-05 | 195 | 124 | 6 | d211a836cf711fdb91b10d512f09d462be937cc5 | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.79e-05 | 195 | 124 | 6 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 195 | 124 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 1.85e-05 | 196 | 124 | 6 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 1.85e-05 | 196 | 124 | 6 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.90e-05 | 197 | 124 | 6 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.90e-05 | 197 | 124 | 6 | 2a90422ba400b951517603a916f34221056d0f3d | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.90e-05 | 197 | 124 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Control-gd_T|Control / Disease condition and Cell class | 1.90e-05 | 197 | 124 | 6 | 000b3269c152d80527b5ad9412dd4e71b73ef1ca | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.95e-05 | 198 | 124 | 6 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.95e-05 | 198 | 124 | 6 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 2.07e-05 | 200 | 124 | 6 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.07e-05 | 200 | 124 | 6 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.07e-05 | 200 | 124 | 6 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Cilia-bearing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 2.07e-05 | 200 | 124 | 6 | 177f9ad8dd8635394c575a2b30140184df0bd51e | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-3|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 4.10e-05 | 137 | 124 | 5 | a1e34ebbeda3d5a4f14917282d44fcb4dcbf3133 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.82e-05 | 157 | 124 | 5 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.89e-05 | 165 | 124 | 5 | 6d8b5669eee9b0903c9260fea707d186c9d7fefa | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.89e-05 | 165 | 124 | 5 | 02cd87dfa2ca40e13455a4b9308477e82f76289b | |
| ToppCell | COVID-CD8-exh_CD4|COVID / Condition, Cell_class and T cell subcluster | 1.02e-04 | 166 | 124 | 5 | 4ca8c91b03d08489f244898cf9423b9d10348bc8 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-04 | 167 | 124 | 5 | 754e6412d3b9cc0b126e59593df2f5956b4712ef | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.08e-04 | 168 | 124 | 5 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.11e-04 | 169 | 124 | 5 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.11e-04 | 169 | 124 | 5 | ea600c63cf9572bc4b3cad6392f67bd0d92c7fc9 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-04 | 171 | 124 | 5 | 26b34dc069cc15b75a0c13cb8c5d81e074788160 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.20e-04 | 172 | 124 | 5 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-RGCs_early_2|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.34e-04 | 176 | 124 | 5 | 8e0ac3ad5e47614b4befabd674a40e3eaae553f3 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-04 | 177 | 124 | 5 | 8a74f5e72de605774111057bd87a7e7e4a6385cd | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_proliferating_1|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-04 | 179 | 124 | 5 | ec69e1dd897414033ba5b007aa82655a79adca6c | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 1.45e-04 | 179 | 124 | 5 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 1.49e-04 | 180 | 124 | 5 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-04 | 181 | 124 | 5 | d66838fca0429cad2079cd8d92a5cd33eb0d3522 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.56e-04 | 182 | 124 | 5 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 183 | 124 | 5 | 0e8fb371d8eac777451c76f41d53577f5dfb740d | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 183 | 124 | 5 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.60e-04 | 183 | 124 | 5 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 1.60e-04 | 183 | 124 | 5 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 183 | 124 | 5 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 183 | 124 | 5 | cbc3b00faa7e4e0dbbbc8ee105467c65241c7470 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 184 | 124 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.65e-04 | 184 | 124 | 5 | 55dde9c4eebac2a33788c1ff1d8fe312d150fad4 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 184 | 124 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 184 | 124 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.65e-04 | 184 | 124 | 5 | 7128a2be291544d3df3ed6c80f21ddda8437dcba | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.65e-04 | 184 | 124 | 5 | d14238f7b0b55a4c8d7040bea854bd221a66ac30 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 184 | 124 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.65e-04 | 184 | 124 | 5 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 184 | 124 | 5 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 1.69e-04 | 185 | 124 | 5 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.69e-04 | 185 | 124 | 5 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.69e-04 | 185 | 124 | 5 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.69e-04 | 185 | 124 | 5 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.69e-04 | 185 | 124 | 5 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.73e-04 | 186 | 124 | 5 | 799903b68bc6f6205d004b44c603424b0d5f7c32 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.73e-04 | 186 | 124 | 5 | 1a1e5d85a5ad90afee234c12a9b54a5e93a8a2f2 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.73e-04 | 186 | 124 | 5 | f1366638edaecad5cad6367440f4c693513bed7e | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 186 | 124 | 5 | b58db5abdd3e9f0214b198c3cbd09b0b3c321eab | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 186 | 124 | 5 | 37860daeecd6d412bd3797f30496a56da667fbd1 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 186 | 124 | 5 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-04 | 186 | 124 | 5 | a6ef5d5944af5689b5f27bef89cd05645eedbe50 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 186 | 124 | 5 | cd6502bbf9dce318fdbb4965d49df8951e5f795c | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 186 | 124 | 5 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 186 | 124 | 5 | 60830822d3de3147816693404fd03392e04c2b8e | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 186 | 124 | 5 | baebeffdd426ce767190ddefc857cc78e6a58d36 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.73e-04 | 186 | 124 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.77e-04 | 187 | 124 | 5 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | 21-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 1.77e-04 | 187 | 124 | 5 | 1a2178a195d078d1963947b327c6d0d4f2f48341 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.77e-04 | 187 | 124 | 5 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| Drug | Succimer | HNRNPDL RAD18 HIVEP1 CDC42BPA ANK3 TRAF3IP1 ENPP2 ERO1A ZMYND8 CAST RFTN2 HUNK CWC22 FAM13B DNAJC2 CEP170 RIF1 RHOV ZNF638 CLSPN TOP2A | 2.28e-06 | 1264 | 119 | 21 | ctd:D004113 |
| Drug | Magnetite Nanoparticles | HNRNPDL RAD18 HIVEP1 CDC42BPA ANK3 TRAF3IP1 ENPP2 ERO1A ZMYND8 CAST RFTN2 HUNK CWC22 FAM13B DNAJC2 CEP170 RIF1 RHOV ZNF638 CLSPN TOP2A | 3.99e-06 | 1310 | 119 | 21 | ctd:D058185 |
| Disease | Majewski Syndrome | 2.25e-05 | 14 | 119 | 3 | C0024507 | |
| Disease | prostate carcinoma (is_marker_for) | 1.07e-04 | 23 | 119 | 3 | DOID:10286 (is_marker_for) | |
| Disease | Clear cell sarcoma of kidney | 2.39e-04 | 6 | 119 | 2 | C0334488 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 3.34e-04 | 7 | 119 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | Cardiomegaly | 3.45e-04 | 82 | 119 | 4 | C0018800 | |
| Disease | Cardiac Hypertrophy | 3.45e-04 | 82 | 119 | 4 | C1383860 | |
| Disease | unipolar depression, bipolar disorder | 4.36e-04 | 156 | 119 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | Neurodevelopmental Disorders | 5.57e-04 | 93 | 119 | 4 | C1535926 | |
| Disease | Mood Disorders | 6.10e-04 | 168 | 119 | 5 | C0525045 | |
| Disease | alopecia areata (is_marker_for) | 7.11e-04 | 10 | 119 | 2 | DOID:986 (is_marker_for) | |
| Disease | schizophrenia (is_marker_for) | 7.51e-04 | 44 | 119 | 3 | DOID:5419 (is_marker_for) | |
| Disease | chronotype measurement | CYLC1 RAD18 DRD2 HIVEP1 ANK3 TRAF3IP1 MYCBP2 KIF16B CIR1 RFTN2 CCDC12 | 8.99e-04 | 882 | 119 | 11 | EFO_0008328 |
| Disease | overall survival, pancreatic carcinoma | 1.03e-03 | 49 | 119 | 3 | EFO_0000638, EFO_0002618 | |
| Disease | diet measurement | ZMYND11 DRD2 ANK3 GAP43 CAST CHD2 CCDC12 CIT NEK1 TRANK1 ZNF608 CHD6 | 1.11e-03 | 1049 | 119 | 12 | EFO_0008111 |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 1.22e-03 | 13 | 119 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | Short Rib-Polydactyly Syndrome | 1.22e-03 | 13 | 119 | 2 | C0036996 | |
| Disease | Polydactyly | 1.31e-03 | 117 | 119 | 4 | C0152427 | |
| Disease | electrocardiography | 1.41e-03 | 530 | 119 | 8 | EFO_0004327 | |
| Disease | Saldino-Noonan Syndrome | 1.42e-03 | 14 | 119 | 2 | C0036069 | |
| Disease | pulse pressure measurement | PDE8A GAP43 NEK10 ENPP2 CHD2 SMOC2 CWC22 PIK3R4 PRDM11 TRANK1 ANKRD11 ZNF638 HYDIN DNMT1 | 1.47e-03 | 1392 | 119 | 14 | EFO_0005763 |
| Disease | Synostotic Posterior Plagiocephaly | 1.87e-03 | 16 | 119 | 2 | C1833340 | |
| Disease | Craniosynostosis, Type 1 | 1.87e-03 | 16 | 119 | 2 | C4551902 | |
| Disease | Acrocephaly | 1.87e-03 | 16 | 119 | 2 | C0030044 | |
| Disease | Trigonocephaly | 1.87e-03 | 16 | 119 | 2 | C0265535 | |
| Disease | Scaphycephaly | 1.87e-03 | 16 | 119 | 2 | C0265534 | |
| Disease | Synostotic Anterior Plagiocephaly | 1.87e-03 | 16 | 119 | 2 | C2931150 | |
| Disease | Narcolepsy-Cataplexy Syndrome | 1.87e-03 | 16 | 119 | 2 | C0751362 | |
| Disease | Metopic synostosis | 1.87e-03 | 16 | 119 | 2 | C1860819 | |
| Disease | Multiple congenital anomalies | 2.11e-03 | 17 | 119 | 2 | C0000772 | |
| Disease | Brachycephaly | 2.11e-03 | 17 | 119 | 2 | C0221356 | |
| Disease | a disintegrin and metalloproteinase with thrombospondin motifs 13 measurement | 2.11e-03 | 17 | 119 | 2 | EFO_0008011 | |
| Disease | Narcolepsy | 2.11e-03 | 17 | 119 | 2 | C0027404 | |
| Disease | Myeloid Leukemia | 2.37e-03 | 18 | 119 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 2.37e-03 | 18 | 119 | 2 | C0023466 | |
| Disease | Grand Mal Status Epilepticus | 2.54e-03 | 67 | 119 | 3 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 2.54e-03 | 67 | 119 | 3 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 2.54e-03 | 67 | 119 | 3 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 2.54e-03 | 67 | 119 | 3 | C0751523 | |
| Disease | Petit mal status | 2.54e-03 | 67 | 119 | 3 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 2.54e-03 | 67 | 119 | 3 | C0393734 | |
| Disease | Status Epilepticus | 2.65e-03 | 68 | 119 | 3 | C0038220 | |
| Disease | mean platelet volume | SEMA4F ZMYND8 KIF16B ELOVL5 DYNC2I1 SMOC2 CWC22 TRANK1 SETBP1 DIAPH1 ANKRD11 | 2.82e-03 | 1020 | 119 | 11 | EFO_0004584 |
| Disease | Craniosynostosis | 2.92e-03 | 20 | 119 | 2 | C0010278 | |
| Disease | cortical surface area measurement | ANO4 ERO1B PDE8A ANK3 GAP43 MYCBP2 ENPP2 RFTN2 SMOC2 DNAH7 BMP2 IL17RD PDZRN3 | 3.06e-03 | 1345 | 119 | 13 | EFO_0010736 |
| Disease | response to clopidogrel, cardiovascular event measurement | 3.86e-03 | 23 | 119 | 2 | EFO_0006919, GO_1903493 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KRAFKTNGKPEEKNH | 191 | Q5SW79 | |
| RHKTDPSAAGRKKKQ | 2291 | Q96L91 | |
| RQKEKGKSPAHLKDK | 271 | Q6ZSZ5 | |
| SLKRKDPKDHEKENL | 91 | Q9H0I2 | |
| PANLKKRKERAKAEH | 276 | Q8IVF6 | |
| KRKERAKAEHNLKVA | 281 | Q8IVF6 | |
| SEFEKGLKHKAKNPE | 321 | Q6UB99 | |
| KSSDKQHPERQKDKE | 1166 | Q6UB99 | |
| ADAGRDKKEKVFEKH | 1191 | Q6UB99 | |
| QKLPEKAEKKHAAED | 1236 | Q6UB99 | |
| LRHRSGDPKLKEKAK | 1611 | Q6UB99 | |
| KDEKKHRSQPKDLAA | 281 | P26358 | |
| DKKGAKSLKEEFRLH | 366 | Q86YB8 | |
| KDEAHQAQKDPKKDR | 476 | Q13362 | |
| KKIEQRHGTKNKPAA | 11 | P59074 | |
| LQKERKERKKNGKAH | 936 | Q32M45 | |
| RIKKEKEKPNSAHRN | 56 | O60610 | |
| GKGHPLHKREKRQAK | 271 | P12643 | |
| GKAKSLQKLDPHQKD | 501 | Q99543 | |
| CQHKLLKAKDQGKPE | 606 | O14578 | |
| RKDKLKNEKELHSEP | 106 | Q9H8W3 | |
| SNKGKRKHKNEDDNR | 761 | Q9UHB7 | |
| LEARKKAKNKQLGHE | 536 | P25098 | |
| FNHPKEAAKLREKRK | 551 | Q96L93 | |
| HKALKKEALRAGKRE | 181 | Q9UPQ7 | |
| LSDRDLKKKLKEHGL | 251 | Q9NS91 | |
| DKKASRHIKGEDKNK | 411 | Q52LD8 | |
| DRNKHIHKKRKLAEG | 361 | Q9NVR2 | |
| HKLDGKLIDPKRAKA | 211 | O14979 | |
| GKKRKHKRDAPLSDL | 556 | Q8NDF8 | |
| ISRKKKHQAEPKDKH | 4206 | Q14517 | |
| LDREKNREHDKPEKK | 291 | Q8TDR0 | |
| LKHEGPFKRKTCKQE | 236 | Q8NFM7 | |
| KAKLRGEKKEANHSE | 576 | Q96PY6 | |
| KKRVDHCPIKSRKGD | 36 | P26885 | |
| KKGASRRKDHLKDHQ | 256 | Q9NYP7 | |
| LRKQIKDAKHKNSDG | 616 | Q9NYF5 | |
| DLENKHGDPKKKRGE | 811 | Q9HCG8 | |
| QSGGSKEERKHREKK | 26 | Q8WVS4 | |
| ALGSHKEKENLKPAK | 71 | A6NNH2 | |
| GKEKDKDAKKHNLGI | 256 | Q8N5G2 | |
| NLHNPAFGKDKKDRD | 551 | Q6ZWH5 | |
| KHKDRRKGSLDVKAV | 351 | O60658 | |
| HDKRKLEEGQKPAHK | 61 | P35663 | |
| KLEDDSFPTHKRKAK | 1956 | Q5H8C1 | |
| KEKNTKKVDHRAPGA | 556 | Q53F19 | |
| APLRKKKPDKHEDNR | 326 | Q8WWI1 | |
| RLAGKELRFHKEKKD | 306 | Q8IVB5 | |
| RLKHADDKPAVKAAD | 671 | Q86VQ0 | |
| KIPHKEVDKADGKQL | 41 | Q9NX02 | |
| VKKDNEKERHKLFQG | 271 | Q68DK7 | |
| KSLGDSKNRHKKPKD | 241 | Q8IZQ8 | |
| DPRLKKHLQDKTDGK | 401 | O94913 | |
| KDSSHRAKLPLAKEK | 986 | Q8NFC6 | |
| KRKQKKRDALAASHE | 121 | Q9GZV1 | |
| KDKDHPKFKRDGSNI | 236 | Q9UDY4 | |
| RKHKGALEKEKERLQ | 2286 | Q4G0P3 | |
| KKKKRKQAAEEHPGD | 591 | Q9P2K1 | |
| HRDPEKAKLDKSKQG | 356 | Q14241 | |
| VKKENKVPRLKEEHG | 1346 | O14647 | |
| EHKEPKQKDGAKKAR | 141 | Q8TD26 | |
| KSKGKSPHKERENFR | 111 | Q8WXX0 | |
| FHAVQDKKPKEQEKR | 431 | P57058 | |
| DKKPKEQEKRGDFLH | 436 | P57058 | |
| LKAAKDPDAVAVKNH | 41 | A6NFZ4 | |
| INAEEEPEKKRKHRK | 16 | Q12955 | |
| LDHGHEKPQDKKKRT | 46 | Q9P203 | |
| GDKKEAHKLKEDFRL | 366 | Q96HE7 | |
| KEKAKAEHRDKLGER | 596 | P20810 | |
| ISRIHEEFKKKKNDP | 506 | Q8N4S9 | |
| KLHEDLDKIRGKFKQ | 101 | Q8WV07 | |
| EKNGHAKDHPKIAKI | 326 | P14416 | |
| RKDKEDGEPKTKHLR | 31 | Q8WUD4 | |
| GRRNVADHKKGAKKA | 431 | Q92769 | |
| ADHKKGAKKARIEED | 436 | Q92769 | |
| HSGREGRKNKKEPKE | 721 | Q9ULU4 | |
| DPTLNDKKAKKLEHQ | 266 | Q8NE79 | |
| KNKLDELNKRLHTKG | 576 | Q13822 | |
| KADLRDLFQKAAKKH | 626 | Q92523 | |
| DHEEQDKVRPKAKRK | 151 | O75586 | |
| KRHDSDKEEKGRKEP | 421 | Q99549 | |
| RKGDPLVSRKEKKQH | 861 | A6NNL0 | |
| RKGDPLVSRKEKKQH | 861 | B1AL46 | |
| ECKVDHKKGLRKSEN | 171 | Q2TAK8 | |
| RGDIEHKKRKAKEAA | 171 | Q9GZR2 | |
| KQHEGSKKKAAARDV | 486 | P49591 | |
| QDAPKLKKRALSHAD | 506 | Q8N1G1 | |
| TDLKEQRKESGKNKH | 21 | O75575 | |
| EAHRQNCRKKGKKED | 106 | O95754 | |
| KQHQGNKDAKDKVER | 76 | Q9NUQ6 | |
| KPEDKAHKAATKIQA | 26 | P17677 | |
| NSHQKKERRKEEEKP | 1436 | Q5UIP0 | |
| AKRSHKRKQKPEEEA | 1296 | P57071 | |
| FDEGDVHPQAKKKKI | 321 | Q9NQV5 | |
| KDKSNKNRETHPRKE | 51 | A0A5F9ZH02 | |
| PAQLKHKRDKHKDGS | 901 | O75592 | |
| KREGIHANEIKNLKK | 706 | Q5VT25 | |
| HHNREKAKEKPRFLK | 326 | Q86X95 | |
| SQAEKHLPRKSDKKE | 921 | Q9HAW4 | |
| TKQEPDDKRARKHVK | 836 | Q99570 | |
| DRDCDSHPGKKKEKI | 81 | Q8N6M9 | |
| ELEGTRPNKKFKCKH | 536 | Q9ULJ3 | |
| PKGRNHLKKAKDDRA | 341 | Q70YC5 | |
| IEHKARLEKKLNAKG | 206 | Q96L33 | |
| VHLDEDQNPIKKRKK | 286 | Q8NEJ9 | |
| RDLTDQHKEKRDKKP | 526 | Q13129 | |
| QHKEKRDKKPIGSSE | 531 | Q13129 | |
| AQKRKLADKTDHKGE | 151 | Q6NW29 | |
| AKEDGKADTKKRHTP | 416 | Q9H3U7 | |
| KKKKNLHRASAPEQS | 26 | Q5MJ08 | |
| EAHEKNRKNKRKAEA | 11 | Q9BZA0 | |
| QKAHKEASLRKDPRN | 1681 | Q9HCK1 | |
| AKLLGKEDRPNSKKH | 851 | Q8TBZ2 | |
| KEDRPNSKKHKAKDD | 856 | Q8TBZ2 | |
| KHEKLKKALNAEEAR | 521 | O95391 | |
| STDDKKPGERKIKRH | 151 | Q9Y6A9 | |
| FRRAKAHEKLDNKKE | 191 | O94826 | |
| KDKGKDKELHNIKRG | 151 | Q96IZ7 | |
| AKKHAGERDKKLAAK | 196 | Q16763 | |
| KHNRIKGIPKLDDAN | 431 | P11388 | |
| ERAIDLNKKGKDNKH | 171 | Q15326 | |
| AKRDKDAGKSRKDKH | 201 | Q9ULD9 | |
| RLSLKNDAPQAKHKK | 46 | Q8N567 | |
| NKEGKDARHRIKKND | 581 | O15050 | |
| EHKAAGEKALKKAIA | 396 | Q9NRG4 | |
| KPHSKSKKRHLDQEQ | 106 | Q14669 | |
| PKHKRKRKSLQNRDD | 936 | Q9Y6X0 | |
| GKKHKKNAARVALLE | 166 | Q9H898 | |
| RSKALAQGPHIEKKK | 936 | P15822 | |
| RSPHKRKRNKDKDKN | 301 | Q6IEG0 | |
| KLDFHEAQQKKGKPH | 86 | Q14966 | |
| HPTDKKGNRKKRAVD | 1801 | Q14966 | |
| QSHDDPKDKKEKRAQ | 61 | Q9UBP6 | |
| EEGKERPEKEQSKHK | 546 | Q5H9K5 | |
| KDLKQKHPEKDLDQL | 321 | P57103 | |
| GNILKKHAAEQAKKA | 366 | P57103 | |
| KQNLLHSEKRDKKSP | 286 | O14974 |